Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE2A | O00408 | 16/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4016258 | 0.84 | PDE2A (0.41) | PDE2AALDH1A1 | |
| SCHEMBL4012512 | 0.78 | LMNA (0.45) | PDE2AALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL5199168 | 0.75 | TSHR (0.50) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL5325968 | 0.73 | MEN1 (0.40) | PDE2AALDH1A1MEN1KMT2A | |
| SCHEMBL9824226 | 0.72 | ALDH1A1 (0.44) | ALDH1A1HSD17B10 | |
| SCHEMBL457105 | 0.72 | ALDH1A1 (0.44) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL9770335 | 0.71 | HSD17B10 (0.56) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL7597284 | 0.71 | ALDH1A1 (0.43) | ALDH1A1HSD17B10MEN1KMT2A | |
| SCHEMBL3227894 | 0.71 | PDE2A (0.39) | PDE2A | |
| SCHEMBL9312143 | 0.71 | PDE2A (0.39) | PDE2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7550471-B2 | 5-alkyl-7-aminotriazolopyrimidines, methods and intermediary product necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms | BASF AKTIENGESELLSCHAFT (DE) | 2009-06-23 | — | — | US | disclosed |
| WO-2007113136-A1 | USE OF SUBSTITUTED TRIAZOLOPYRIMIDINES FOR CONTROLLING PHYTOPATHOGENIC HARMFUL FUNGI | BASF AKTIENGESELLSCHAFT (DE) | 2007-10-11 | — | — | WO | disclosed |
| EP-1585747-B1 | 5-ALKYL-7-AMINOTRIAZOLOPYRIMIDINES, METHODS AND INTERMEDIATES SUITABLE FOR THEIR PRODUCTION, AGENTS CONTAINING THEM AND THEIR USE FOR CONTROLLING HARMFUL FUNGI | BASF AG (DE) | 2006-09-13 | — | — | EP | disclosed |
| US-20050272749-A1 | 5-Alkyl-7-aminotriazolopyrimidines, methods and intermediary product necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms | BASF AKTIENGESELLSCHAFT (DE) | 2005-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050272749-A1 | 5-Alkyl-7-aminotriazolopyrimidines, methods and intermediary product necessary for the production thereof, agents containing said compounds and the use thereof for fighting against harmful mushrooms | ERG28, CBR3, CBR1 | PDE2A 2277/4885ALDH1A1 850/4885HSD17B10 3419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.